2014

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Investigation of DUSA Pharmaceuticals Inc. (DUSA), Schiff Nutrition International, Inc. (SHF) and The Warnaco Group, Inc. (WRC) and Class Action Against Questcor Pharmaceuticals, Inc. (QCOR)

NEW YORK, Nov. 8, 2012 /PRNewswire/ --

DUSA Pharmaceuticals Inc.
Levi & Korsinsky is investigating the Board of Directors of DUSA Pharmaceuticals Inc. (Nasdaq: DUSA) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Sun Pharmaceutical Industries Limited (Reuters: SUN.BO) for $8 per share.

Click here to learn more about the investigation: http://zlk.9nl.com/dusa-pharmaceuticals-dusa, or call: 877-363-5972.

(Logo: http://photos.prnewswire.com/prnh/20120409/MM84375LOGO )

Schiff Nutrition International, Inc.
Levi & Korsinsky is investigating the Board of Directors of Schiff Nutrition International, Inc. (NYSE: SHF) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Bayer HealthCare, LLC for $34 per share.

Click here to learn more about the investigation: http://zlk.9nl.com/shiff-nutrition-international-shf, or call: 877-363-5972.

The Warnaco Group, Inc.
Levi & Korsinsky is investigating the Board of Directors of The Warnaco Group, Inc. (NYSE: WRC) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to PVH Corp. under which shareholders will receive $51.75 in cash and 0.1822 of a PVH common share per share.

Click here to learn more about the investigation http://zlk.9nl.com/warnaco-group-wrc, or call: 877-363-5972.

Questcor Pharmaceuticals, Inc.
Levi & Korsinsky announces that a class action lawsuit has been commenced in the USDC for the Central District of California on behalf of investors who acquired Questcor Pharmaceuticals, Inc. (NasdaqGS: QCOR) securities between April 26, 2011 and September 21, 2012.

For more information, click here: http://zlk.9nl.com/questcor-pharmaceuticals-qcor. You have until November 26, 2012 to request that the Court appoint you as lead plaintiff.   

Levi & Korsinsky is a national firm with offices in New York and Washington D.C.  The firm has extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits.  Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:     
Levi & Korsinsky, LLP
Joseph Levi, Esq.
Eduard Korsinsky, Esq.
30 Broad Street - 24th Floor 
New York, NY 10004
Tel: (212) 363-7500
Toll Free:  (877) 363-5972
Fax: (212) 363-7171
www.zlk.com

SOURCE Levi & Korsinsky, LLP



RELATED LINKS
http://www.zlk.com

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

 

PR Newswire Membership

Fill out a PR Newswire membership form or contact us at (888) 776-0942.

Learn about PR Newswire services

Request more information about PR Newswire products and services or call us at (888) 776-0942.